Healthy Clinical Trial
Official title:
Brain Mechanisms of Emotion and Motivation: A Mind-Body Study
The purpose of this research study is to investigate how the brain processes emotions, and the way these processes affect behavior. Specifically, we hypothesize that individual differences in reward responsiveness will correlate with differential activation in mesolimbic regions of the brain and predict future wellbeing in follow-up interviews.
The purpose of this research study is to investigate how the brain processes emotions, and
the way these processes affect behavior. Specifically, we hypothesize that individual
differences in reward responsiveness will correlate with differential activation in
mesolimbic regions of the brain and predict future wellbeing in follow-up interviews.
Participating in this study involves up to two sessions and up to 7.5 hours. In the present
observational study, each participant will be exposed to the same experimental procedure.
Visit 1 will take about 4.5 hours, from 12pm to 4:30pm. The visit will take place at the
Center for Depression, Anxiety and Stress at McLean. During this visit, a clinical
interviewer will conduct a diagnostic SCID interview to ensure that participants qualify to
take part in this research study. Participants will then complete several tasks. These tasks
include several different "game-like" situations and arithmetic riddles, all of which are
simple but require participants to work hard and remain alert for an extended period of time.
The goal during these games is to earn as much money as you can or to avoid losing money.
Participants will do so by responding (pressing a keyboard button) quickly and accurately.
These tasks are intended as assessment tools, and are not a form of therapy or intervention.
In addition, we will test participants' ability to keep their hand in cold water.
Participants will also be asked to provide blood (via a saline IV) and saliva samples at
different times during this session, and we will also conduct urine drug and pregnancy tests.
The IV will be in place for a total of around 3 hours, and is used to reduce discomfort from
multiple blood draws.
Visit 2 will take place at the McLean Imaging Center at McLean Hospital. During the first
part of the session, the fMRI scanner will take structural pictures of brain anatomy. Next,
additional images will be obtained while participants complete several different "game-like"
tasks, similar to the tasks performed in visit 1. Again, these tasks are intended as
assessment tools, and are not a form of therapy or intervention. The whole fMRI session will
last up to about 2.5 hours; participants will spend about 1.5 hours in the fMRI machine, and
about a half-an-hour completing questionnaires and providing saliva samples. Prior to the
fMRI scan, another urine sample will be obtained to check for drugs which may interfere with
the experiment.
After the second study session is complete, participants will be re-contacted through the
internet every four weeks for a total of six months, to complete some questionnaires. At the
end of six months, participants will be asked to return to McLean to complete an in-person
interview. This follow-up period is purely observational and not intended to assess health
outcomes, as there is no intervention in this study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |